Atuhaire Bridget, Muteebwa Laban, Nabunya Racheal, Muhindo Richard, Ngabirano Tom Denis, Osingada Charles Peter, Muwanguzi Patience A
Department of Nursing, School of Health Sciences, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.
School of Medicine, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.
AIDS Res Ther. 2024 Dec 20;21(1):95. doi: 10.1186/s12981-024-00686-5.
We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours.
Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18-25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors.
More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year.
Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students' studies to increase awareness and acceptance.
鉴于乌干达一所公立大学的女学生存在较高的艾滋病毒风险行为流行率,我们评估了她们使用长效卡博特韦(CAB-LA)预防艾滋病毒的意愿。
这项横断面研究通过在线问卷对346名年龄在18至25岁之间的本科女学生进行了调查。使用修正泊松回归和稳健标准误分析影响她们意愿的因素。
超过一半,即56.7%(95%置信区间:51.4%至61.8%)的人愿意使用CAB-LA。意愿与过去3个月有性行为、过去6个月饮酒或与一年级学生相比处于四年级显著相关。
应在大学生学习早期引入关于创新艾滋病毒预防策略(如CAB-LA)的教育举措,以提高认识和接受度。